
What smart money is saying about IDEXX Laboratories, Inc.
5 funds in our archive have pitched IDEXX Laboratories, Inc. — most recently Baron Growth Fund in December 2025.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Fund coverage · 5 theses
- Baron Growth FundDecember 2025
IDEXX Laboratories, Inc. is a veterinary diagnostics leader with strong execution, proprietary innovation, and secular pet-care tailwinds supporting durable growth.
Read the full thesis - Polen Global GrowthJune 2025
Backed by dominant market share and recurring revenues, IDEXX Labs offers long-term growth potential in pet diagnostics with defensive traits and renewed valuation appeal as pandemic-era pet care demand begins to normalize.
Read the full thesis - Platinium AMJune 2025
IDEXX is a leading global provider of veterinary diagnostics and software, enabling veterinarians to deliver rapid, in-clinic testing while generating continuous revenue through high-margin consumables.
Read the full thesis - Macquarie Large Cap Growth FundMarch 2025
IDEXX Laboratories Inc. is an animal health company poised for growth as the demand for veterinary services and diagnostics increases following the pandemic pet boom.
Read the full thesis - Baron Focused Growth FundDecember 2024
IDEXX Laboratories, Inc. is expected to achieve accelerated growth and strong financial performance due to the pandemic-driven increase in pet ownership, improved foot traffic, and its significant pricing power.
Read the full thesis
Read every full thesis on IDEXX Laboratories, Inc.
Unlock all 5 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→